Skip to main content

Table 2 Summary ORs and 95% CI of CCND1 G870A polymorphisms and cervical cancer risk

From: Association between cyclin D1 G870A polymorphism and cervical cancer risk: a cumulative meta-analysis involving 2,864 patients and 3,898 controls

   A vs. G GA vs. GG AA vs. GG GA + AA vs. GG AA vs. GG + GA
  N* OR 95% CI P I2(%)a OR 95% CI P I2(%)a OR 95% CI P I2(%)a OR 95% CI P I2(%)a OR 95% CI P I2(%)a
Total 10 1.02 0.88-1.19 0.76 74.5 0.98 0.77-1.26 0.90 69.1 1.03 0.75-1.41 0.85 75.9 1.00 0.78-1.28 0.99 72.3 1.06 0.85-1.32 0.62 70.1
HWE 8 1.01 0.86-1.18 0.92 71.9 1.08 0.85-1.39 0.52 62.2 1.00 0.72-1.39 0.99 73.1 1.06 0.82-1.36 0.66 68.7 0.97 0.79-1.20 0.79 59.8
Ethnicity                      
Caucasian 5 0.99 0.79-1.25 0.95 78.1 0.84 0.52-1.35 0.47 82.8 0.92 0.56-1.52 0.75 79.8 0.87 0.54-1.39 0.55 84.5 1.13 0.97-1.30 0.11 1.3
Asian 5 1.05 0.84-1.33 0.65 76.1 1.11 0.88-1.40 0.38 25.6 1.13 0.70-1.83 0.61 77.1 1.10 0.86-1.41 0.44 40.4 1.06 0.68-1.65 0.79 83.9
Design                      
Healthy base 4 0.98 0.71-1.36 0.91 76.8 0.88 0.47-1.64 0.70 78.1 0.90 0.45-1.78 0.76 77.5 0.89 0.47-1.67 0.71 81.3 1.02 0.79-1.31 0.91 6.7
Hospital base 4 1.11 0.87-1.40 0.40 71.7 0.99 0.60-1.63 0.96 79.4 1.24 0.75-2.07 0.40 74.5 1.06 0.68-1.66 0.80 76.6 1.25 0.82-1.89 0.30 77.1
Population base 2 0.94 0.64-1.39 0.76 91.0 1.08 0.91-1.28 0.38 0.0 0.87 0.39-1.95 0.73 91.2 1.00 0.70-1.44 0.99 72.7 0.85 0.42-1.70 0.64 92.0
Genotyping type                      
PCR-RFLP 8 1.00 0.82-1.23 0.97 78.3 0.94 0.67-1.33 0.73 75.3 0.98 0.64-1.51 0.93 79.6 0.96 0.68-1.34 0.79 77.3 1.04 0.77-1.40 0.80 74.9
Other 2 1.12 1.01-1.25 0.03 0.0 1.11 0.92-1.33 0.27 0.0 1.25 1.02-1.54 0.03 0.0 1.16 0.97-1.37 0.10 0.0 1.17 0.99-1.39 0.06 0.0
  1. *Numbers of comparisons aTest for heterogeneity. The significance of the bold values are all 0.03.